NIMG-11. IDENTIFYING EARLY INDICATORS OF IMMUNOTHERAPEUTIC RESPONSE: CAR T-CELL THERAPY

The current guideline to assess radiological changes in response to immunotherapy, iRANO, faces critical challenges in the determination of progressive disease during the first 6 months from the start of therapy. In patients with recurrent glioblastoma (GBM), immunotherapy induces an inflammatory re...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Neuro Oncol
Prif Awduron: De Leon, Gustavo, Johnston, Sandra, Hawkins-Daarud, Andrea, Singleton, Kyle, Jackson, Pamela, Rickertsen, Cassandra, Bayless, Spencer, Porter, Alyx, Mrugala, Maciej, Bendok, Bernard, Rodriguez, Analiz, Badie, Behnam, Sahoo, Prativa, Rockne, Russell C, Brown, Christine, Swanson, Kristin R
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2017
Pynciau:
Abstracts
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5693082/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.590
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg